Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 619

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

Shah, Manisha H., Goldner, Whitney S., Benson, Al B., Bergsland, Emily, Blaszkowsky, Lawrence S., Brock, Pamela, Chan, Jennifer, Das, Satya, Dickson, Paxton V., Fanta, Paul, Giordano, Thomas, Halfdanarson, Thorvardur R., Halperin, Daniel, He, Jin, Heaney, Anthony, Heslin, Martin J., Kandeel, Fouad, Kardan, Arash, Khan, Sajid A., Kuvshinoff, Boris W., Lieu, Christopher, Miller, Kimberly, Pillarisetty, Venu G., Reidy, Diane, Salgado, Sarimar Agosto, Shaheen, Shagufta, Soares, Heloisa P., Soulen, Michael C., Strosberg, Jonathan R., Sussman, Craig R., Trikalinos, Nikolaos A., Uboha, Nataliya A., Vijayvergia, Namrata, Wong, Terence, Lynn, Beth, Hochstetler, Cindy·2021·Journal of the National Comprehensive Cancer Network
DOI 10.6004/jnccn.2021.0032
Open this paper in CoChat — free account

Abstract

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Neuroendocrine and Adrenal Gland Tumors focus on the diagnosis, treatment, and management of patients with neuroendocrine tumors (NETs), adrenal tumors, pheochromocytomas, paragangliomas, and multiple endocrine neoplasia. NETs are generally subclassified by site of origin, stage, and histologic characteristics. Appropriate diagnosis and treatment of NETs often involves collaboration between specialists in multiple disciplines, using specific biochemical, radiologic, and surgical methods. Specialists include pathologists, endocrinologists, radiologists (including nuclear medicine specialists), and medical, radiation, and surgical oncologists. These guidelines discuss the diagnosis and management of both sporadic and hereditary neuroendocrine and adrenal tumors and are intended to assist with clinical decision-making. This article is focused on the 2021 NCCN Guidelines principles of genetic risk assessment and counseling and recommendations for well-differentiated grade 3 NETs, poorly differentiated neuroendocrine carcinomas, adrenal tumors, pheochromocytomas, and paragangliomas.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.6004/jnccn.2021.0032

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 619

Metadata

Authors
Shah, M. H., Goldner, W. S., Benson, A. B., Bergsland, E., Blaszkowsky, L. S., Brock, P., Chan, J., Das, S., Dickson, P. V., Fanta, P., Giordano, T., Halfdanarson, T. R., Halperin, D., He, J., Heaney, A., Heslin, M. J., Kandeel, F., Kardan, A., Khan, S. A., Kuvshinoff, B. W., Lieu, C., Miller, K., Pillarisetty, V. G., Reidy, D., Salgado, S. A., Shaheen, S., Soares, H. P., Soulen, M. C., Strosberg, J. R., Sussman, C. R., Trikalinos, N. A., Uboha, N. A., Vijayvergia, N., Wong, T., Lynn, B., & Hochstetler, C.
Venue
Journal of the National Comprehensive Cancer Network
Publisher
Harborside Press, LLC
Published
2021-07
Volume
19
Issue
7
Pages
839-868
ISSN
  • 1540-1405 (ISSN-L)
  • 1540-1413
DOI
10.6004/jnccn.2021.0032
OpenAlex
W3192494717
Cited by
619
References
10
FWCI
59.28
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. https://app.cochat.ai/papers/10.6004/jnccn.2021.0032
The paper
Shah, M. H., Goldner, W. S., Benson, A. B., Bergsland, E., Blaszkowsky, L. S., Brock, P., Chan, J., Das, S., Dickson, P. V., Fanta, P., Giordano, T., Halfdanarson, T. R., Halperin, D., He, J., Heaney, A., Heslin, M. J., Kandeel, F., Kardan, A., Khan, S. A., . . . Hochstetler, C. (2021). Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. https://doi.org/10.6004/jnccn.2021.0032

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.